B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FFAR1

MOLECULAR TARGET

free fatty acid receptor 1

UniProt: O14842NCBI Gene: 286410 compounds

FFAR1 (free fatty acid receptor 1) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FFAR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1fasiglifam3.7843
2dodecanoate3.0420
3gw95083.0019
4Linoleic Acid2.4811
5alpha-Linolenic Acid2.208
6Dehydroepiandrosterone Sulfate1.614
7Oleic Acid1.393
8Myristic Acid1.393
9Palmitic Acid1.393
10gamma-Linolenic Acid0.691

About FFAR1 as a Drug Target

FFAR1 (free fatty acid receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented FFAR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FFAR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.